Collect. Czech. Chem. Commun. 2008, 73, 229-246
https://doi.org/10.1135/cccc20080229

Synthesis of Some Impurities and/or Degradation Products of Atorvastatin

Jan Stach*, Jaroslav Havlíček, Lukáš Plaček and Stanislav Rádl

Zentiva, U kabelovny 130, 102 37 Prague 10, Czech Republic

References

1. Graul A., Castaner J.: Drugs Fut. 1997, 22, 956. <https://doi.org/10.1358/dof.1997.022.09.423212>
2. The Merck Index, 13th ed., p. 148. Merck & Co., Whitehouse Station, U.S.A. 2001.
3. Hájková M., Kratochvíl B., Rádl S.: Chem. Listy 2008, 102, 3.
4. Brower P. L., Butler D. E., Deering C. F., Le Tung V., Millar A., Nanninga T. N., Roth B. D.: Tetrahedron Lett. 1992, 33, 2279. <https://doi.org/10.1016/S0040-4039(00)74189-X>
5. Baumann K. L., Butler D. E., Deering C. F., Mennen K. E., Millar A., Nanninga T. N., Palmer C. W., Roth B. D.: Tetrahedron Lett. 1992, 33, 2283. <https://doi.org/10.1016/S0040-4039(00)74190-6>
6. Rádl S.: Synth. Commun. 2003, 33, 2275. <https://doi.org/10.1081/SCC-120021507>
7. Rádl S., Stach J. (Léčiva Praha): WO 03/068739 A1; Chem. Abstr. 2003, 139, 185711.
8. Hurley T. R., Colson C. E., Clippert S. A., Uhlendorf S. E., Reily M. D.: Tetrahedron 1993, 49, 1979. <https://doi.org/10.1016/S0040-4020(01)86297-9>
9. Rádl S., Stach J., Hájíček J.: Tetrahedron Lett. 2002, 43, 2087. <https://doi.org/10.1016/S0040-4039(02)00175-2>
10a. Butler D. E., Deering C. F., Millar A., Nanninga T. N., Roth B. D. (Warner–Lambert Co.): U.S. 4 681 893; Chem. Abstr. 1987, 107, 198087.
10b. Briggs C. A., Jennings R. A., Wade R., Harasawa K., Ichikawa S., Minohara K., Nakagawa S. (Warner–Lambert Co.): U.S. 5 969 156; Chem. Abstr. 1997, 126, 212037.
10c. McKenzie A. T. (Warner–Lambert Co.): U.S. 6 121 461; Chem. Abstr. 1997, 126, 204216.
11. Nanninga T. N., Le Tung V., Millar A., Butler D. (Warner–Lambert Co.): U.S. 5 155 251; Chem. Abstr. 1993, 118, 41188.
12. Stetter H.: Angew. Chem., Int. Ed. Engl. 1976, 15, 639. <https://doi.org/10.1002/anie.197606391>